<DOC>
	<DOCNO>NCT00315107</DOCNO>
	<brief_summary>Oral estrogen may effective adjuvant treatment control acromegaly patient resistance somatostatin analog .</brief_summary>
	<brief_title>Estrogen Treatment Acromegalic Women</brief_title>
	<detailed_description>This canadian multicenter study randomize , double-blind , placebo-controlled design , assess efficacy safety adjuvant alesse female acromegalic patient suboptimal response sandostatin LAR treatment .</detailed_description>
	<mesh_term>Acromegaly</mesh_term>
	<criteria>Women 18 year older treat somatostatin analog Active acromegaly Cardiovascular cerebrovascular disease Thrombophlebitis thromboembolism Breast cancer Noncontrolled arterial hypertension Smoking Pregnancy lactation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
</DOC>